An interventional study of Brain computer interface in Cerebral Palsy, Pediatric Stroke and Genetic Condition, sponsored by University of Calgary. Recruiting at 2 sites in Canada. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-05-05.
Sponsored by University of Calgary · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Cerebral Palsy by University of Calgary — 4 open to participants now, 4 under way, none of them phase 3. Cerebral Palsy · University of Calgary.
Among the 11 studies in Cerebral Palsy by University of Calgary, this one is the 9th largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2025, is one of 6 with no phase, and was the 9th registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →4 of the 11 studies in Cerebral Palsy by University of Calgary are open now, in 1 country. Recruiting first, the newest first:
University of Calgary · Sites in Canada
Ages 8–17
University of Calgary · Sites in Canada
Ages 4+
University of Calgary · Sites in Canada
Ages 5–17
By country, each count listing its studies:
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 5 Years to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 1
First in 2010; this study’s year is marked. 2 started in 2025.
This study's planned enrollment of 18 is below the median of 34 across 1,434 interventional studies indexed under Cerebral Palsy.
Median enrollment 22 across the 10 interventional studies, 1 across the 1 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Calgary is the lead sponsor of 704 studies on the registry; 197 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 2 (20%) have results posted.
2 of the studies in Cerebral Palsy by University of Calgary that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06407219University of CalgaryEvaluating the Impacts of a Single Session of Robot Assisted Gait Training With a Trexo | 2026-12 |
| NCT07073378University of CalgaryBCI@Home: Brain Computer Interface Solutions to Enable Youth Living With Severe Disabilities | 2027-08-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 11 studies in Cerebral Palsy by University of Calgary, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this trial is to evaluate use of brain computer interfaces (BCI) at home for children with severe severe physical disabilities. The main questions it aims to answer are:
Preliminary research has proven that children with severe physical disabilities can operate home BCI systems. Despite the incredible impact of BCI on child well-being, access is currently limited to those who are close to major centres with the resources to frequently access tertiary care sites. A home-based BCI program is necessary to make this technology equitably available so that every child can realize their fundamental human right to participate in life.
The objectives are to: (1) Evaluate the effectiveness of a home BCI program for enabling children with disabilities to achieve personalized life participation goals; (2) Evaluate the equitable reach of implementation of a home BCI program.
This is a prospective, family-centered, single arm hybrid effectiveness-implementation trial that uses mixed methods. Implementation and effectiveness outcomes will be examined in parallel to ensure the program remains effective as its reach expands.
Implementation Methods: The trial uses systematic implementation science methods focused on the sustainable uptake of research into real-world practice. The four phases of the Quality Implementation Framework will guide implementation. Phase one focuses on identifying adaptations/strategies. Our transdisciplinary team will co-create four strategies to begin: 1) ready access to technical support, 2) scheduling flexibility, 3) broad choice of BCI activities, and 4) culturally safe care. Phase two focuses on creating a structure for implementation by formalizing plans and teams. The third phase, ongoing structure, will include monitoring and adapting strategies as needed during sequential participant enrolment. Phase four, improve future applications, will be done through evaluation outlined in outcomes below.
Home Program: Families will first complete an in-person visit to review available activities, set their first goals, and learn to use BCI independently. A BCI "kit" will be given to each family, with a headset and the equipment and software required to pursue their identified goals. Following this, families will participate in 12 virtual sessions over 3-6 months. Scheduling will be flexible to accommodate complex family needs. Daily online support will be provided via a messaging application. Participants who choose to continue using BCI beyond 12 sessions will be provided kits and supported.
Implementation Outcomes: The primary implementation outcome is the proportion of children recruited from equity-deserving groups. A baseline survey will capture comprehensive demographics. Secondary outcomes span the categories of the RE-AIM evaluation framework (Reach, Effectiveness, Adoption, Implementation, and Maintenance). These outcomes will be continuously monitored with ongoing analysis using the appropriate descriptive statistics.
Effectiveness Outcomes: The primary effectiveness outcome is achievement of child and family-identified participation-based goals, as measured by the Canadian Occupational Performance Measure (COPM). Secondary outcomes will assess quality of life, family BCI experiences (via semi-structured interviews), and health economics. Primary analyses will assess the clinical and statistical significance of pre/post changes, and secondary regression analyses will explore potential response predictors including equity-deserving factors. Inductive thematic analysis will be used for interview transcripts. Finally, brain activity via electroencephalography (EEG) data from all BCI sessions will be captured. These data will be critical to accelerate options and accuracy of pediatric-focused BCI systems.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Home BCI use. Families will first complete an in-person visit to review available activities, set their first goals, and learn to use BCI independently. A BCI "kit" will be given to each family, with a headset and the equipment and software required to pursue their identified goals. Following this, families will participate in 12 virtual sessions over 3-6 months. Scheduling will be flexible to accommodate complex family needs. Daily online support will be provided via a messaging application. Participants who choose to continue using BCI beyond 12 sessions will be provided kits and supported.
Device: Brain computer interface
Families will first complete an in-person visit to review available activities, set their first goals, and learn to use BCI independently. A BCI "kit" will be given to each family, with a headset and the equipment and software required to pursue their identified goals. Following this, families will participate in 12 virtual sessions over 3-6 months. Scheduling will be flexible to accommodate complex family needs. Daily online support will be provided via a messaging application. Participants who choose to continue using BCI beyond 12 sessions will be provided kits and supported.
Canadian Occupational Performance Measure
The primary effectiveness outcome is achievement of child and family-identified participation-based goals, as measured by the Canadian Occupational Performance Measure (COPM). Participants/families will set 3-5 goals, and then score the Importance, Performance, and Satisfaction with each goal on a 1-10 scale.
Time frame: Baseline and end of treatment at 6 months
Implementation Reach
The primary implementation outcome is the proportion of children recruited from equity-deserving groups. A baseline survey will capture comprehensive demographics.
Time frame: through study completion, an average of 2 years
Plan to share: Undecided
No publications or documents are linked to this record.
Started Nov 2025 (actual). Primary completion is estimated for Aug 2027, 21 months after the start.
Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 21 months is above that.
Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.